ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

dexketoprofen

Also written as “Dexketoprofen Trometamol + Tramadol Hydrochloride”, “Dexketoprofen/Tramadol-single dose” and “Dexketoprofen/Tramadol-multiple doses”.

Its studies are mostly in Acute Pain · Dysmenorrhea · Low Back Pain · Venous Thrombosis · Pain, led by 2 companies.

Drug pageDexketoprofen: every studyAll 47 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since May 13, 20168 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Menarini Groupits history only60 open or runningphase 4since May 13, 2016Feb 28, 2011none ahead
Laboratorios Silanes S.A. de C.V.20 open or runningphase 3since Jul 29, 2021Jul 29, 2021none ahead

Also a collaborator on its studies: Simbec Research and PRA Health Sciences.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Laboratorios Silanes S.A. de C.V. only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jul 29, 2021First study: phase 3 study in Acute Low Back PainFirst studyNCT05001555 · 174 enrolled · Mexico
  2. Oct 14, 2026Phase 3 study in Primary DysmenorrheaNCT07901894 · 130 enrolled · Mexico

TargetBeta

PTGS1 →PTGS2 →read by rule
“Cyclooxygenase inhibitor”ChEMBL 37, by rule

Other programs on the same two targets

ProgramCompanyFurthest phaseStudies
AcetaminophenruleJohnson & Johnsonphase 4136
IbuprofenrulePfizerphase 4113
AspirinruleBayerphase 484
SulfasalazineruleBristol-Myers Squibbphase 47
dexibuprofenruleaponia-laboratories-incphase 46
BenzydamineruleAngelini Pharmaphase 44
DipyroneruleHypera Pharmaphase 44
PiroxicamruleTaisho Pharmaceuticalphase 44
FlurbiprofenruleGlaxoSmithKlinephase 312

Studies

All 2 Laboratorios Silanes S.A. de C.V. leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07901894Primary Dysmenorrhea · Mexico3CompletedMay 7, 2026130
NCT05001555Acute Low Back Pain · Mexico3CompletedApr 24, 2023174

How it is read

Names in the registry

  • “Dexketoprofen Trometamol + Tramadol Hydrochloride”, 4 entries
  • “Dexketoprofen/Tramadol-single dose”, 2 entries
  • “Dexketoprofen/Tramadol-multiple doses”, 2 entries
  • “Dexketoprofen / Butylscopolamine in fixed dose combination tablet. (Laboratorios Silanes S.A. de C.V.)”, 1 entry
  • “Dexketoprofen/Vitamin B”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.